QUARK VENTURE
Established in 2015, Quark Venture Inc. is a venture capital investment firm, headquartered in Vancouver, Canada, and is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
QUARK VENTURE
Social Links:
Founded:
2015-01-01
Status:
Active
Contact:
604-262-8818
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Domain Not Resolving Wordpress Plugins Mobile Non Scaleable Content Google Maps PHP
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Karimah Es Sabar
Karimah Es Sabar Chief Executive Officer & Partner @ Quark Venture Chief Executive Officer & Partner 2016-09-21
Jesson Chen
Jesson Chen Co-Founder, Chairman & Partner @ Quark Venture Co-Founder, Chairman & Partner
Neena Kadaba
Neena Kadaba Director, Science @ Quark Venture Director, Science 2017-01-01
Zafrira Avnur
Zafrira Avnur Chief Scientific Officer @ Quark Venture Chief Scientific Officer
Founder
Jesson Chen
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-24 | Lyndra Therapeutics | Quark Venture investment in Series C - Lyndra Therapeutics | 60.5 M USD |
2021-04-06 | Volastra Therapeutics | Quark Venture investment in Seed Round - Volastra Therapeutics | 32 M USD |
2021-03-11 | CalciMedica | Quark Venture investment in Series D - CalciMedica | 21 M USD |
2020-09-22 | V-Wave | Quark Venture investment in Series C - V-Wave | 28 M USD |
2020-02-19 | EnClear Therapies | Quark Venture investment in Series A - EnClear Therapies | 10 M USD |
2020-02-11 | Volastra Therapeutics | Quark Venture investment in Seed Round - Volastra Therapeutics | 12 M USD |
2020-01-08 | Eyevensys | Quark Venture investment in Series B - Eyevensys | 30 M USD |
2019-12-18 | Raziel Health | Quark Venture investment in Series C - Raziel Health | 22 M USD |
2019-12-03 | Raziel Therapeutics | Quark Venture investment in Series C - Raziel Therapeutics | 2 M USD |
2019-05-29 | Pi Therapeutics | Quark Venture investment in Series B - Pi Therapeutics | 19.7 M USD |